A joint team of researchers from POSTECH and Georgia Institute of Technology successfully created an engineered heart via 3D printing technology that allows for early monitoring of drug-induced cardiotoxicity
News | Medical 3-D Printing
In Vitro 3D Engineered Heart Tissue that Monitors Drug-induced Cardiotoxicity

March 29, 2023 — Cardiotoxicity is a clinical condition that arises from using pharmaceutical agents such as antibiotics ...

Home March 29, 2023
Home
DAIC JAHA Sleep Irregularity study image
News | Cardiovascular Clinical Studies
Multi-Ethnic Study of Atherosclerosis Sheds Light on Sleep Irregularity and Cardiovascular Disease

March 29, 2023 — Irregular sleep patterns may play a role in the pathophysiologic development of cardiovascular disease ...

Home March 29, 2023
Home
People exposed to low doses of ionizing radiation have an extra, but modest, risk of developing heart disease during their lifetime, according to a new study
News | Heart Failure
Low-dose Radiation Linked to Heart Disease

March 28, 2023 — People exposed to low doses of ionizing radiation have an extra, but modest, risk of developing heart ...

Home March 28, 2023
Home
Royal Philips has announced the debut of a comprehensive approach to telehealth with Philips Virtual Care Management. The solution’s condition-specific protocols now include heart disease and hypertension, as well as other chronic conditions. Photo credit: Getty Images
News | Remote Monitoring
Philips Debuts Remote Patient Management Solution

March 28, 2023 — Royal Philips has announced its debut of Philips Virtual Care Management, a comprehensive approach to ...

Home March 28, 2023
Home
ECGenius System and CARDIALYTICS Suite recognized as critical to the evolution of electrophysiology
News | EP Lab
CathVision Announces Key Milestones in Advance of ECGenius Commercial Launch

March 28, 2023 — CathVision, a medical technology company developing innovative electrophysiology solutions designed to ...

Home March 28, 2023
Home
The Society for Cardiovascular Angiography and Interventions (SCAI) and the Heart Rhythm Society (HRS) released an updated expert consensus statement on transcatheter left atrial appendage closure (LAAC)
News | Left Atrial Appendage (LAA) Occluders
SCAI and HRS Release Expert Consensus on Transcatheter Left Atrial Appendage Closure

March 28, 2023 — The Society for Cardiovascular Angiography and Interventions (SCAI) and the Heart Rhythm Society (HRS) ...

Home March 28, 2023
Home
PH-HFpEF affects more than 1,600,000 North Americans, with estimates indicating a prevalence of more than 2,000,000 patients by 2030
News | Cardiovascular Clinical Studies
Tenax Announces Issuance of U.S. Patent Covering Use of IV Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)

March 27, 2023 — Tenax Therapeutics, Inc., a specialty pharmaceutical company focused on identifying, developing and ...

Home March 27, 2023
Home
Extends HeartBeam’s reach with FDA-cleared Halo+ atrial fibrillation detection system and physician-prescribed integrated patient care platform
News | ECG
HeartBeam Announces Acquisition of LIVMOR Assets Extending Reach with FDA-cleared Halo+ Atrial Fibrillation Detection System

March 27, 2023 — HeartBeam, Inc., a cardiac technology company that has developed the first and only 3D-vector ...

Home March 27, 2023
Home
An analysis based on the EAST – AFNET 4 trial
News | Atrial Fibrillation
Is Early Rhythm Control in Atrial Fibrillation Care Cost-effective?

March 27, 2023 — Patients with atrial fibrillation (AF) benefit from early rhythm control therapy. It reduces ...

Home March 27, 2023
Home
The recalled product is used as an oral anticoagulant to lower the risk of stroke and blood clots.
News | Antiplatelet and Anticoagulation Therapies
Ascend Laboratories Issues Voluntary Nationwide Recall of Dabigatran Etexilate Capsules Due to the Detection of NDMA Impurity

March 24, 2023 — According to the U.S. Food and Drug Administration (FDA), Ascend Laboratories LLC is voluntarily ...

Home March 24, 2023
Home
CardioMEMS is a tiny implantable sensor that can remotely flag early warning signs of worsening heart failure
News | Heart Failure
New Data Show Remote Monitoring Technology Like Abbott’s Cardiomems Helps Improve Survival in Heart Failure Patients

March 24, 2023 — Abbott announced new data that found monitoring patients remotely with hemodynamic pressure sensing ...

Home March 24, 2023
Home
The Vascular Verification Program establishes a cohesive framework for hospitals focused on using data and quality improvement practices to deliver appropriate clinical care to achieve optimal vascular patient outcomes
News | Cardiovascular Surgery
The American College of Surgeons and the Society for Vascular Surgery Launch National Quality Verification Program for Vascular Care

March 24, 2023 — The American College of Surgeons (ACS), with the Society for Vascular Surgery (SVS), has launched a new ...

Home March 24, 2023
Home
Vaxxinity Headquarters Ground View (cropped)
News | Cardiovascular Clinical Studies
Clinical Trial of Investigational Vaccine to Treat LDL Cholesterol Underway

March 24, 2023 — Vaxxinity, Inc., a Cape Canaveral, FL-based company pioneering the development of a new class of ...

Home March 24, 2023
Home
AiMed Summit 2023
Feature | AIMed | By Melinda Taschetta-Millane
AiMed 2023: Changing Healthcare One Connection at a Time

The 2023 AiMed Global Summit will focus on artificial intelligence (AI) in healthcare, and will offer valuable insights ...

Home March 23, 2023
Home
A newly-published study in the European Society of Cardiology’s European Heart Journal is shedding new light on the obesity paradox.
News | ESC
Study Puts ‘Obesity Paradox’ in Spotlight: Waist-to-height Ratio Better Than BMI as Indicator of Outcomes in Patients with Heart Failure

March 23, 2023 — Newly-published research has debunked the idea that there is an “obesity paradox,” whereby patients ...

Home March 23, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now